Yayın:
Central nervous system fungal infections in children with leukemia and undergoing hematopoietic stem cell transplantation: A retrospective multicenter study

dc.contributor.buuauthorMERAL GÜNEŞ, ADALET
dc.contributor.buuauthorBaytan, Birol
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.departmentHematoloji Bilim Dalı
dc.contributor.scopusid 24072843300
dc.contributor.scopusid6506622162
dc.date.accessioned2025-05-13T06:32:39Z
dc.date.issued2022-11-01
dc.descriptionÇalışmada 41 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır.
dc.description.abstractBackground: Central nervous system fungal infections (CNSFI) are seen in patients with hematologic malignancies and have high morbidity and mortality. Because of their rarity, there is limited data on CNSFI in children with no established treatment protocols or guidelines. Materials and Methods: In this multicenter retrospective study, 51 pediatric patients with leukemia, 6 of whom had undergone bone marrow transplantation, with proven or probable CNSFI were evaluated. Fungal infections were defined as proven or probable based on European Organisation for Research and Treatment of Cancer criteria. Proven CNSFI was diagnosed by appropriate central nervous system (CNS) imaging or tissue sample findings in combination with positive microbiological results of cerebrospinal fluid. A positive culture, microscopic evidence of hyphae, a positive result of the galactomannan assays are defined as positive microbiological evidence. Probable CNSFI was defined as appropriate CNS imaging findings together with proven or probable invasive fungal infections at another focus without CNS when there is no other explanatory condition. Data was collected by using the questionnaire form (Supplemental Digital Content 1, http://links.lww.com/JPHO/A541). Results: Seventeen patients had proven, 34 patients had probable CNSFI. Headaches and seizures were the most common clinical findings. The median time between the onset of fever and diagnosis was 5 days. The most common fungal agent identified was Aspergillus. Sixteen patients received single-agent, 35 received combination antifungal therapy. Surgery was performed in 23 patients. Twenty-two patients (43%) died, 29 of the CNSFI episodes recovered with a 20% neurological sequelae. Conclusion: CNSFIs should be considered in the differential diagnosis in patients with leukemia and refractory/recurrent fever, headache, neurologicalocular symptoms, and a radiologic-serological evaluation should be performed immediately. Early diagnosis and prompt management, both medical and surgical, are essential for improving clinical outcomes.
dc.identifier.doi10.1097/MPH.0000000000002499
dc.identifier.endpageE1045
dc.identifier.issn1077-4114
dc.identifier.issue8
dc.identifier.scopus2-s2.0-85140932665
dc.identifier.startpageE1039
dc.identifier.urihttps://hdl.handle.net/11452/51653
dc.identifier.volume44
dc.indexed.scopusScopus
dc.language.isoen
dc.publisherLippincott Williams and Wilkins
dc.relation.journalJournal of Pediatric Hematology/Oncology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPediatrics
dc.subjectLeukemia
dc.subjectFungal infections
dc.subjectCentral nervous system
dc.titleCentral nervous system fungal infections in children with leukemia and undergoing hematopoietic stem cell transplantation: A retrospective multicenter study
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı/Hematoloji Bilim Dalı
local.indexed.atScopus
relation.isAuthorOfPublication500825a8-5e0f-481f-a84f-d7fb8759c049
relation.isAuthorOfPublication.latestForDiscovery500825a8-5e0f-481f-a84f-d7fb8759c049

Dosyalar